Autoimmune hypophysitis (lymphocytic hypophysitis)

Overview

Autoimmune hypophysitis, also known as lymphocytic hypophysitis, is a rare immune-mediated condition characterized by inflammation of the pituitary gland. This inflammation can impair the gland’s ability to produce hormones, leading to partial or complete hypopituitarism. The exact cause is not fully understood, but it is believed to involve an abnormal immune response in which the body mistakenly targets pituitary tissue.

Autoimmune hypophysitis, particularly the lymphocytic form, is generally considered a confirmed autoimmune condition based on evidence of immune-mediated damage to the pituitary gland. However, some related forms, including those associated with IgG4-related disease or certain cancer immunotherapies, are classified as immune-mediated rather than strictly autoimmune.

Common Symptoms

Headache, absence of menstruation in females, sexual dysfunction in males, visual disturbances, and diplopia.

Coexisting Diseases and Conditions

Risk Factors and Prevalence

Research states that females are 3 times more likely to get autoimmune hypophysitis than males. The condition also is more likely to occur during the third trimester of pregnancy or early postpartum period.

Sources

  1. Article Sources
    1. Gutenberg, A., Landek-Salgado, M., Tzou, S.-C., Lupi, I., Geis, A., Kimura, H., & Caturegli, P. (2009). Autoimmune hypophysitis: Expanding the differential diagnosis to CTLA-4 blockade. Expert Review of Endocrinology & Metabolism, 4(6), 681–698. https://doi.org/10.1586/eem.09.37.

    2. Rose, N. R., & Mackay, I. R. (2020). The Autoimmune Diseases (6th ed., pp. 815–828). Academic Press.

    3. Dalmazi, G. Di, Caturegli, P. & Chalan, P. Chapter 43 – Autoimmune Hypophysitis. in The Autoimmune Diseases (Sixth Edition) (eds. Rose, N. R. & Mackay, I. R.) 815–830 (Academic Press, 2020). doi:https://doi.org/10.1016/B978-0-12-812102-3.00043-9.

    4. Iwama S, De Remigis A, Callahan MK, Slovin SF, Wolchok JD, Caturegli P. “Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody.” Sci Transl Med. 2014 Apr 2;6(230):230ra45. doi: 10.1126/scitranslmed.3008002